UPDATE 1-Exelixis and Pfizer drugs compete in kidney cancer trial By: Reuters: Company News October 10, 2016 at 03:32 AM EDT * Pfizer's Sutent helps patients after kidney cancer surgery (Adds Exelixis planning to seek approval based on study results) Read More >> Related Stocks: Exelixis Inc Pfizer